Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Class action filed
Director departure
Appointed director
CC transcript
INSPIRE PHARMACEUTICALS INC (ISPH) Create: Alert

All | News | Filings
Date FiledTypeDescription
05/16/2011 8-K Quarterly results
05/10/2011 8-K Other Events
05/10/2011 8-K Form 8-K - Current report
04/22/2011 8-K Form 8-K - Current report
03/29/2011 8-K Other Events
03/16/2011 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
02/17/2011 8-K Form 8-K - Current report
01/03/2011 8-K Form 8-K - Current report
12/22/2010 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "API Commercial Supply Agreement (Denufosol), by and between Inspire Pharmaceuticals, Inc. and Finorga S.A.S",
"Parent Guarantee from Groupe Novasep S.A.S. concerning the terms of the API Commercial Supply Agreement (Denufosol), by and between Inspire Pharmaceuticals, Inc. and Finorga S.A.S"
11/04/2010 8-K Quarterly results
Docs: "INSPIRE REPORTS THIRD QUARTER 2010 FINANCIAL RESULTS"
08/25/2010 8-K Form 8-K - Current report
08/13/2010 8-K Form 8-K - Current report
08/05/2010 8-K Form 8-K - Current report
07/01/2010 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Separation of Employment and Consulting Agreement",
"INSPIRE ANNOUNCES MANAGEMENT STRUCTURE CHANGES"
07/01/2010 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Lease Agreement between Inspire Pharmaceuticals, Inc. and Brier Creek Corporate Center Associates Limited Partnership"
06/10/2010 8-K Form 8-K - Current report
06/08/2010 8-K Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
Docs: "Amended and Restated 2010 Equity Compensation Plan",
"Amended and Restated Certificate of Incorporation"
05/03/2010 8-K Quarterly results
Docs: "INSPIRE REPORTS FIRST QUARTER 2010 FINANCIAL RESULTS - First Quarter 2010 Revenue Increased 54% from First Quarter 2009 -"
04/01/2010 8-K Form 8-K - Current report
03/05/2010 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "INSPIRE ELECTS GEORGE ABERCROMBIE TO BOARD OF DIRECTORS"
03/04/2010 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "INSPIRE REPORTS FOURTH QUARTER AND FULL YEAR 2009 FINANCIAL RESULTS - Fourth Quarter Revenue Increased 57% and Net Loss Decreased 74% - - Full Year Revenue Increased 31% and Net Loss Decreased 23% -"
02/24/2010 8-K Form 8-K - Current report
01/21/2010 8-K Other Events, Financial Statements and Exhibits
Docs: "INSPIRE ANNOUNCES RESULTS OF PHASE 3 PROLACRIA™ TRIAL FOR DRY EYE - Primary and Secondary Endpoints Not Met -"
12/23/2009 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
12/14/2009 8-K Regulation FD Disclosure
11/05/2009 8-K Form 8-K - Current report
09/22/2009 8-K Investor presentation
Docs: "Presentation made on September 22, 2009 at the UBS Global Life Science Conference in New York, New York"
08/13/2009 8-K Form 8-K - Current report
08/10/2009 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "Underwriting Agreement, between Inspire Pharmaceuticals, Inc. and Deutsche Bank Securities Inc",
"Opinion of Reed Smith, LLP",
"Amendment No. 1 to Standstill Agreement, between Inspire Pharmaceuticals, Inc. and Warburg Pincus Private Equity IX, L.P"
07/31/2009 8-K Quarterly results
Docs: "INSPIRE REPORTS SECOND QUARTER 2009 FINANCIAL RESULTS - 2009 Annual Financial Guidance Reaffirmed - - CEO Succession Plan Announced -"
07/13/2009 8-K Form 8-K -- Current report
05/07/2009 8-K Form 8-K -- Current report
03/03/2009 8-K Form 8-K -- Current report
02/12/2009 8-K Form 8-K -- Current report
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy